M&A Deal Summary

Altaris Acquires HealthTronics

On February 3, 2014, private equity firm Altaris acquired medical products company HealthTronics from Endo International for 130M USD

Acquisition Highlights
  • This is Altaris’ 8th transaction in the Medical Products sector.
  • This is Altaris’ 7th largest (disclosed) transaction.
  • This is Altaris’ 15th transaction in the United States.
  • This is Altaris’ 1st transaction in Texas.

M&A Deal Summary
Date 2014-02-03
Target HealthTronics
Sector Medical Products
Buyer(s) Altaris
Sellers(s) Endo International
Deal Type Divestiture
Deal Value 130M USD

Target

HealthTronics

Austin, Texas, United States
HealthTronics provides mobile equipment services, medical devices and information technology solutions to the urology industry. The company partners with physician groups to facilitate equipment ownership and to provide logistical support for mobile lithotripsy, laser and cryoablation units. In addition, HealthTronics offers a line of cryoablation devices as well as a urology-specific IT platform. HealthTronics was founded in 1972 and is based in Austin, Texas.

Search 200,577 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Altaris

New York City, New York, United States
Category Private Equity Firm
Founded 2003
PE ASSETS 10.0B USD
Size Mega
Type Sector Focused
DESCRIPTION

Altaris is a specialist private equity firm that targets investments in the healthcare industry. Altaris focuses its investment activity across the healthcare sector, including pharmaceuticals, medical devices, healthcare services and healthcare IT. Altaris will consider both control and non-control investment situations requiring $15 to $50 million of equity capital. Prospective investment situations include corporate carve-outs, leveraged buyouts, and growth equity/recapitalization investments. Altaris was formed in 2004 and is based in New York, New York.

DEAL STATS #
Overall 16 of 36
Sector (Medical Products) 8 of 13
Type (Divestiture) 1 of 6
State (Texas) 1 of 4
Country (United States) 15 of 34
Year (2014) 2 of 2
Size (of disclosed) 7 of 8
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2014-01-22 Quantum Health

Dublin, Ohio, United States

Quantum Health is a consumer healthcare navigation company that delivers an unparalleled consumer experience based on empathy and trust, enabling employers to achieve industry-leading satisfaction rates and independently validated claim savings. Quantum Health’s model is based on years of consumer research and the insights learned from guiding millions of consumers and their providers through their healthcare journey. Quantum Health was founded in 1999 and is based in Dublin, Ohio.

Buy -
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-02 OSO BioPharmaceuticals Manufacturing

Albuquerque, New Mexico, United States

OsoBio is a leading contract manufacturer of injectable pharmaceutical products. The company provides glass vial filling and lyophilization services for drugs and biologics that are either approved for commercial marketing or in clinical development. With facilities equipped to handle highly potent and toxic active pharmaceutical ingredients, OsoBio focuses on the production of products that require special or complex handling.

Sell $110M

Seller(S) 1

SELLER

Endo International

Dublin, Ireland
Category Company
Founded 1920
Sector Medical Products
Employees3,103
Revenue 2.9B USD (2020)
DESCRIPTION

Endo International is a pharmaceutical company engaged in the research, development, sale and marketing of branded and generic prescription pharmaceuticals used to treat and manage pain, bladder cancer, prostate cancer and the early onset of puberty in children, or central precocious puberty (CPP). Endo International was incorporatted in 1920 and is based in Dublin, Ireland.

DEAL STATS #
Overall 1 of 4
Sector (Medical Products) 1 of 2
Type (Divestiture) 1 of 4
State (Texas) 1 of 1
Country (United States) 1 of 2
Year (2014) 1 of 1
Size (of disclosed) 2 of 3
PREVIOUS DEAL
DATE TARGET DEAL TYPE VALUE
2013-08-28 Boca Pharmacal

Coral Springs, Florida, United States

Boca Pharmacal, Inc. provides medical products like tablets and capsules.

Buy $225M
FOLLOWING DEAL
DATE TARGET DEAL TYPE VALUE
2014-06-24 DAVA Pharmaceuticals

Fort Lee, New Jersey, United States

DAVA Pharmaceuticals Inc., a specialty pharmaceuticals company, is focused on developing and marketing a broad portfolio of pharmaceutical products. DAVA is aggressively building its product portfolio through a combination of acquisitions, strategic alliances, in-licensing transactions, partnerships and development. DAVA's headquarters is in Fort Lee, New Jersey.

Buy $575M
Mergr

Product

Company

Legal